Introduction
Congenital muscular dystrophy (MDC) is a group of rare hereditary myopathies characterized by congenital muscular hypotonia, delayed motor development and early onset progressive muscle weakness. Biopsies of affected muscle tissue show dystrophic changes. However, cardiac muscle involvement is rare [1, 2] .
The recorded incidence rate is approximated to be between 2.6x10 -5 and 4.56x10 -5 [3, 4] . An estimated 30 to 40% of all MDC cases in Europe are attributed to laminin-alpha 2-deficiency (MDC1A). The laminin-alpha 2 (LAMA2) gene is located on chromosome 6q22-q23.
LAMA2 protein is known to bind directly to the dystrophin-glycoprotein-complex. The alpha-2 subunit of laminin is also expressed in the basal lamina of the Schwann cell-axon unit and a deficiency can cause congenital muscular dystrophy associated with peripheral motor neuropathy [5] . Patients develop marked muscle weakness and atrophy, diffuse joint contractures, an inability to achieve independent ambulation, facial dysmorphism and significant elevations of creatine kinase (CK) levels in blood serum [1, 2] . A partial deficiency of LAMA2 protein can result in various phenotypes.
Some forms of MDC are associated with severe malformations of the brain or eyes [1, 2] .
In MDC1A cases, MRI scans of the brain show characteristic abnormal findings in the white matter; migration defects of the grey matter are rarely found [6] [7] [8] .
The clinical outcome concerning cognition and speech does not correlate to the changes in white matter detected by MRI [1, 2] . Cortical abnormalities indicate an elevated risk for epilepsy and developmental delay [9] .
Case 1
The first patient, a 10-week-old female, exhibited By the age of 3 years, the girl had continued to grow however no significant motor development could be seen. She was able to turn from her back to her side and remain in a seated position when passively supported. abstract Congenital muscular dystrophy (MDC) is a group of rare hereditary myopathies with an early onset of progressive muscle weakness and dystrophic changes as evidenced by muscle biopsy. Some forms are associated with severe malformations of the brain. This study presented 2 pediatric patients with genetically diagnosed congenital muscular dystrophy 1A. The patients exhibited a typical combination of muscular hypotonia, joint contractures and elevated creatine kinase levels. Characteristic white matter lesions were not present in an early MRI scan of one patient, but could be detected at the age of 18 months. The second patient showed both severe white and grey matter abnormalities (pachy microgyria) in the MRI scan. In both cases, MRI findings did not correlate with the mental development of the patients. 
discussion
This study presents 2 children with genetically For example, in recent publications 2 out of 5 patients with mutations in the LAMA2 gene showed significant cortical changes [7, 16, 17] .
In other published cases, polymicrogyria or focal cortical dysplasias were mainly located occipitally [9, 18] . The underlying mechanisms are not fully understood but they do indicate a role for LAMA2 protein in embryonic neuronal migration. Other functions of LAMA2 protein in embryogenesis such as a participation in peripheral myelogenesis of Schwann cells have been shown in a mouse model [19] . As in case 1, it has been shown that white matter changes found in MRI scans do not correlate with mental and language disabilities [7] . However in cases with migration defects, deterioration of cognitive development is more common [9] .
While mutations causing a complete loss of LAMA2 protein regularly lead to a severe course 
Conclusion
This study presented two pediatric patients with 
